Activity of the Anthelmintic Benzimidazoles against Giardia lamblia In Vitro
Abstract
In vitro growth of the protozoan parasite Giardia lamblia was highly sensitive to certain anthelmintic benzimidazoles. Albendazole and mebendazole were 30- to 50-fold more active than metronidazole and 4- to 40-fold more active than quinacrine. Thiabendazole, a noncarbamate benzimidazole, was less active. Since lack of intestinal absorption makes mebendazole an attractive new antigiardial agent, its in vitro activity was further characterized. At low concentrations (0.05 micrograms/ml) mebendazole had a static effect on G. lamblia growth; however, lethal activity was observed at a concentration fivefold lower (0.3 micrograms/ml) than necessary for the cidal agent metronidazole. Two observations are consistent with a microtubule target for mebendazole. First, attachment of cells to the culture tube, mediated by the ventral disk and flagella, was rapidly disrupted by mebendazole treatment. Second, the characteristic cell structure was grossly distorted by treatment. No mebendazole-resistant G. lamblia were detected in a population of 10(8) cells.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In vitro growth of Giardia spp. is highly sensitive to albendazole and mebendazole, which have 30- to 50-fold higher activity than metronidazole, quinacrine, or tinidazole.
“In vitro growth of Giardia spp. (G. lamblia, G. duodenalis, or G. intestinalis) was found to be highly sensitive to albendazole and mebendazole which had 30- to 50-fold higher activity than metronidazole, quinacrine, or tinidazole [266,267].”
From Albendazole and Mebendazole as Anti-Parasitic and Anti-Cancer Agents: an Update (2021) · cites this paper as [266]
Cited by
Sorted by citations
Albendazole and Mebendazole as Anti-Parasitic and Anti-Cancer Agents: an Update
Chai, J.-Y., Jung, B.-K., & Hong, S.-J. (2021) · The Korean Journal of Parasitology · doi:10.3347/kjp.2021.59.3.189 · Cited by 286 · see citing works
Antiprotozoal activities of benzimidazoles and correlations with beta-tubulin sequence
Katiyar, S. K., Gordon, V. R., McLaughlin, G. L., & Edlind, T. D. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.9.2086 · Cited by 217 · see citing works
Self-citationEfficacy of fenbendazole against giardiasis in dogs
Barr, S. C., Bowman, D. D., & Heller, R. L. (1994) · American Journal of Veterinary Research · doi:10.2460/ajvr.1994.55.07.988 · Cited by 55 · see citing works
- Authors
- Edlind, T. D., Hang, T. L., & Chakraborty, P. R.
- Affiliations
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- Corresponding author
- Edlind, T. D.
- ORCID
- Chakraborty, P. R.
- Venue
- Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 1990-12-01
- Volume
- 162
- Issue
- 6
- Pages
- 1408-1411
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2046832486
- Cited by
- 112
- References
- 0
- Citations by year
- 2026: 1 · 2025: 2 · 2023: 2 · 2022: 1 · 2021: 4 · 2020: 2 · 2019: 2 · 2018: 3 · 2017: 1 · 2015: 3 · 2014: 2 · 2013: 2 · 2012: 3
- FWCI
- 7.20
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Parasitology › Parasitic Infections and Diagnostics
- Health Sciences › Veterinary › Small Animals › Helminth infection and control
- Health Sciences › Medicine › Infectious Diseases › Amoebic Infections and Treatments
- Keywords
- Giardia lamblia, benzimidazole, anthelmintic activity, mebendazole, albendazole, metronidazole, thiabendazole, quinacrine, cell attachment, flagella, drug resistance, giardiasis
- MeSH terms
- Animals, Dose-Response Relationship, Drug, Drug Resistance, Giardia, Mebendazole, Metronidazole, Quinacrine, Thiabendazole, Albendazole
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review